Glycans News and Research

RSS
Researchers probe intriguing interaction between sugars and the SARS-CoV-2 spike protein

Researchers probe intriguing interaction between sugars and the SARS-CoV-2 spike protein

The role and ancestry of the SARS-CoV-2 spike protein glycan shield

The role and ancestry of the SARS-CoV-2 spike protein glycan shield

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

Oxford-AstraZeneca COVID vaccine induces cell spikes similar to SARS-CoV-2's

Oxford-AstraZeneca COVID vaccine induces cell spikes similar to SARS-CoV-2's

Glycans influence SARS-CoV-2 spike–ACE2 binding affinity, finds study

Glycans influence SARS-CoV-2 spike–ACE2 binding affinity, finds study

Virus-cell interaction may partly explain the higher infection rate of COVID-19

Virus-cell interaction may partly explain the higher infection rate of COVID-19

Glycans play a key role in COVID-19 infection, shows study

Glycans play a key role in COVID-19 infection, shows study

Engineering immunogens to focus immune response to SARS-CoV-2

Engineering immunogens to focus immune response to SARS-CoV-2

Novel tool can add or remove sugar from proteins

Novel tool can add or remove sugar from proteins

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

Scientists reprogram a common bacterium to make designer sugar-based drug

Scientists reprogram a common bacterium to make designer sugar-based drug

Researchers study how glycans activate SARS-CoV-2

Researchers study how glycans activate SARS-CoV-2

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains

Full characterization of mammalian-produced SARS-CoV-2 receptor binding domains

Two potent SARS-CoV-2 neutralizing antibodies effective against B.1.351 and B.1.1.7 variants

Two potent SARS-CoV-2 neutralizing antibodies effective against B.1.351 and B.1.1.7 variants

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

Study provides new information about the structure of prion proteins

Study provides new information about the structure of prion proteins

O-glycosylation of SARS-CoV-2 spike protein in insect and human cell lines

O-glycosylation of SARS-CoV-2 spike protein in insect and human cell lines

A glycan controls how SARS-CoV-2’s spike protein opens, study finds

A glycan controls how SARS-CoV-2’s spike protein opens, study finds

The origin of SARS-CoV-2 furin cleavage site remains a mystery

The origin of SARS-CoV-2 furin cleavage site remains a mystery

Inhibition of protein glycosylation successfully prevents SARS-CoV-2 infection in vitro

Inhibition of protein glycosylation successfully prevents SARS-CoV-2 infection in vitro